Podocyte injury in diabetic nephropathy: Implications of angiotensin II - dependent activation of TRPC channels

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Ilatovskaya, Daria V ^a   Levchenko, Vladislav ^a   Lowing, Andrea ^a   Shuyskiy, Leonid S ^a,b   Palygin, Oleg ^a   Staruschenko, Alexander ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CALCIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; TRPC6 PROTEIN, RAT;

AGONISTS; ALBUMINURIA; ANIMAL; DAHL RAT; DIABETIC NEPHROPATHY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; PODOCYTE; RAT;

ALBUMINURIA; ANGIOTENSIN II; ANIMALS; CALCIUM; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; PODOCYTES; RATS; RATS, INBRED DAHL; TRPC CATION CHANNELS;

EID: 84949591115     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17637     Document Type: Article

References (56)

1. Zhang, P. et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87, 293-301 (2010).
2. Tervaert, T. W. et al. Pathologic classification of diabetic nephropathy. J. Am. Soc. Nephrol. 21, 556-563 (2010).
3. Pagtalunan, M. E. et al. Podocyte loss and progressive glomerular injury in type II diabetes. J. Clin. Invest. 99, 342-348 (1997).
4. Wolf, G., Chen, S. & Ziyadeh, F. N. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54, 1626-1634 (2005).
5. Fogo, A. B. The targeted podocyte. J. Clin. Invest. 121, 2142-2145 (2011).
6. Scott, R. P. & Quaggin, S. E. The cell biology of renal filtration. J. Cell Biol. 209, 199-210 (2015).
7. Johnstone, D. B. & Holzman, L. B. Clinical impact of research on the podocyte slit diaphragm. Nat. Clin. Pract. Nephrol. 2, 271-282 (2006).
8. Lee, S. H. et al. Podocyte hypertrophy precedes apoptosis under experimental diabetic conditions. Apoptosis, 20, 1056-1071 (2015).
9. Puelles, V. G. & Bertram, J. F. Counting glomeruli and podocytes: rationale and methodologies. Curr. Opin. Nephrol. Hypertens., 24, 224-230 (2015).
10. Reiser, J. et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat. Genet. 37, 739-744 (2005).
11. Dietrich, A., Chubanov, V. & Gudermann, T. Renal TRPathies. J. Am. Soc. Nephrol. 21, 736-744 (2010).
12. Winn, M. P. et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308, 1801-1804 (2005).
13. Moller, C. C. et al. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J. Am. Soc. Nephrol. 18, 29-36 (2007).
14. Zhang, X., Song, Z., Guo, Y. & Zhou, M. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats. Mol. Cell. Biochem., 399, 155-165 (2014).
15. Schlondorff, J., del Camino, D., Carrasquillo, R., Lacey, V. & Pollak, M. R. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. Am. J. Physiol. Cell Physiol. 296, C558-C569 (2009).
16. Chen, S. et al. Calcium entry via TRPC6 mediates albumin overload-induced endoplasmic reticulum stress and apoptosis in podocytes. Cell Calcium 50, 523-529 (2011).
17. Evans, J. F., Lee, J. H. & Ragolia, L. Ang-II-induced Ca(2+) influx is mediated by the 1/4/5 subgroup of the transient receptor potential proteins in cultured aortic smooth muscle cells from diabetic Goto-Kakizaki rats. Mol. Cell. Endocrinol. 302, 49-57 (2009).
18. Abkhezr, M. & Dryer, S. E. Angiotensin II and canonical transient receptor potential-6 activation stimulate release of a signal transducer and activator of transcription 3-activating factor from mouse podocytes. Mol. Pharmacol. 86, 150-158 (2014).
19. Anderson, M., Kim, E. Y., Hagmann, H., Benzing, T. & Dryer, S. E. Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol. Am. J. Physiol. Cell Physiol. 305, C276-289 (2013).
20. Ilatovskaya, D. V. et al. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli. Kidney Int. 86, 506-514 (2014).
21. Nijenhuis, T. et al. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am. J. Pathol. 179, 1719-1732 (2011).
22. Eckel, J. et al. TRPC6 enhances angiotensin II-induced albuminuria. J. Am. Soc. Nephrol. 22, 526-535 (2011).
23. Zhang, H., Ding, J., Fan, Q. & Liu, S. TRPC6 up-regulation in Ang II-induced podocyte apoptosis might result from ERK activation and NF-kappaB translocation. Exp. Biol. Med. 234, 1029-1036 (2009).
24. Slaughter, T. N. et al. Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305, R727-734 (2013).
25. Patari, A. et al. Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes 52, 2969-2974 (2003).
26. Ilatovskaya, D. V., Palygin, O., Levchenko, V. & Staruschenko, A. Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli. J. Vis. Exp. e52850 (2015).
27. Krall, P. et al. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease. PLoS ONE 5, e12859 (2010).
28. Liu, B. C. et al. High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen species. Biochim. Biophys. Acta 1833, 1434-1442 (2013).
29. Thilo, F., Lee, M., Xia, S., Zakrzewicz, A. & Tepel, M. High glucose modifies transient receptor potential canonical type 6 channels via increased oxidative stress and syndecan-4 in human podocytes. Biochem. Biophys. Res. Commun. 450, 312-317 (2014).
30. Gao, F. et al. Notch pathway is involved in high glucose-induced apoptosis in podocytes via Bcl-2 and p53 pathways. J. Cell. Biochem. 114, 1029-1038 (2013).
31. Li, Z., Xu, J., Xu, P., Liu, S. & Yang, Z. Wnt/beta-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes. Cell Prolif. 46, 76-85 (2013).
32. Li, R. et al. NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression. Exp. Cell Res. 319, 992-1000 (2013).
33. Zhang, L. et al. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice. Br. J. Pharmacol. 170, 426-439 (2013).
34. Yang, H. et al. High glucose-induced apoptosis in cultured podocytes involves TRPC6-dependent calcium entry via the RhoA/ROCK pathway. Biochem. Biophys. Res. Commun. 434, 394-400 (2013).
35. Durvasula, R. V. & Shankland, S. J. Activation of a local renin angiotensin system in podocytes by glucose. Am. J Physiol. Renal Physiol. 294, F830-839 (2008).
36. Palygin, O. et al. Real-time electrochemical detection of ATP and H2O2 release in freshly isolated kidneys. Am. J. Physiol. Renal Physiol. 305, F134-F141 (2013).
37. Anderson, M., Roshanravan, H., Khine, J. & Dryer, S. E. Angiotensin II activation of TRPC6 channels in rat podocytes requires generation of reactive oxygen species. J. Cell. Physiol. 229, 434-442 (2014).
38. Anil Kumar, P., Welsh, G. I., Saleem, M. A. & Menon, R. K. Molecular and cellular events mediating glomerular podocyte dysfunction and depletion in diabetes mellitus. Front. Endocrinol. (Lausanne) 5, 151 (2014).
39. Luan, J. et al. Renal protection of in vivo administration of tempol in streptozotocin-induced diabetic rats. J. Pharmacol. Sci. 119, 167-176 (2012).
40. Sonneveld, R. et al. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner. Am. J. Pathol. 184, 1715-1726 (2014).
41. He, F. et al. MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1. Diabetologia 57, 1726-1736 (2014).
42. Meng, K. et al. Calcium sensing receptor modulates extracellular calcium entry and proliferation via TRPC3/6 channels in cultured human mesangial cells. PLoS ONE 9, e98777 (2014).
43. Wang, Y. et al. Nuclear factor kappaB mediates suppression of canonical transient receptor potential 6 expression by reactive oxygen species and protein kinase C in kidney cells. The J. Biol. Chem. 288, 12852-12865 (2013).
44. Qiu, G. & Ji, Z. AngII-induced glomerular mesangial cell proliferation inhibited by losartan via changes in intracellular calcium ion concentration. Clin. Exp. Med. 14, 169-176 (2014).
45. Adebiyi, A., Soni, H., John, T. A. & Yang, F. Lipid rafts are required for signal transduction by angiotensin II receptor type 1 in neonatal glomerular mesangial cells. Exp. Cell Res. 324, 92-104 (2014).
46. Graham, S. et al. Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes. Am. J. Physiol. Cell Physiol. 301, C304-315 (2011).
47. + signaling in glomerular mesangial cells in diabetes. Am. J. Physiol. Renal Physiol. 293, F1381-1390 (2007).
48. Schiessl, I. M. & Castrop, H. Angiotensin II AT2 receptor activation attenuates AT1 receptor-induced increases in the glomerular filtration of albumin: a multiphoton microscopy study. Am. J. Physiol. Renal Physiol. 305, F1189-1200 (2013).
49. Sharma, R., Sharma, M., Vamos, S., Savin, V. J. & Wiegmann, T. B. Both subtype 1 and 2 receptors of angiotensin II participate in regulation of intracellular calcium in glomerular epithelial cells. J. Lab. Clin. Med. 138, 40-49 (2001).
50. Wang, L., Flannery, P. J. & Spurney, R. F. Characterization of angiotensin II-receptor subtypes in podocytes. J. Lab. Clin. Med. 142, 313-321 (2003).
51. Ilatovskaya, D. & Staruschenko, A. Single-channel analysis of TRPC channels in the podocytes of freshly isolated glomeruli. Methods Mol. Biol. 998, 355-369 (2013).
52. Pavlov, T. S. et al. Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertension. J. Am. Soc. Nephrol. 24, 1053-1062 (2013).
53. Raij, L., Azar, S. & Keane, W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 26, 137-143 (1984).
54. Dworkin, L. D., Feiner, H. D. & Randazzo, J. Glomerular hypertension and injury in desoxycorticosterone-salt rats on antihypertensive therapy. Kidney Int. 31, 718-724 (1987).
55. Ilatovskaya, D. V., Palygin, O., Levchenko, V. & Staruschenko, A. Pharmacological characterization of the P2 receptors profile in the podocytes of the freshly isolated rat glomeruli. Am. J. Physiol. Cell Physiol. 305, C1050-1059 (2013).
56. Peti-Peterdi, J. Calcium wave of tubuloglomerular feedback. Am. J. Physiol. Renal Physiol. 291, F473-F480 (2006).